Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: Clinical outcome

Annals of Clinical Biochemistry

Volumn 39, Issue 4, 2002, Pages 392-397

  Saadeddin, S M ^a   Habbab, M A ^a   Sobki, S H ^a   Ferns, G A ^b  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; TROPONIN I;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BIOCHEMISTRY; CHEMOSENSITIVITY; CLINICAL OBSERVATION; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ANALYSIS; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REFERENCE VALUE; REOPERATION; STENT; SURVIVAL TIME; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; HEART INJURIES; HUMANS; ISOENZYMES; MALE; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TROPONIN I;

ANGINA;

EID: 0036305389     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456302760042155     Document Type: Article

References (22)

1. Significance of mild transient release of creatine kinase MB fraction after percutaneous interventions
2. Prognostic value of creatine kinase elevation following elective coronary interventions
3. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT)
4. The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures
5. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention. A device-specific analysis of 7147 patients
6. Release kinetics of serum cardiac troponin I in ischemic myocardial injury
7. Cardiac troponin I. A marker with high specificity for cardiac injury
8. Cardiac troponin I in the diagnosis of myocardial injury and infarction
9. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
10. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina
11. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin inhibition in myocardial ischemia
12. Prognostic role of troponin T versus I in unstable angina for cardiac events with meta-analysis comparing published studies
13. Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting
14. Cardiac troponin T, creatinine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting
15. Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty
16. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting
17. Prognostic value of cardiac troponin I following catheter-based coronary interventions
18. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures
19. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (committee on percutaneous transluminal coronary angioplasty)
20. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?
21. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting
22. Release of creatine kinase-MB and cardiac specific troponin I following percutaneous transluminal coronary angioplasty